Cancer cells are not thought to be sources of IFNγ, but MHC-I expression can be directly regulated by type I interferon (IFN-I) signaling and studies have indicated that host responses to IFN-I through the receptor IFNAR are essential to the anti-cancer CD8+ T cell response driven by radiotherapy18. Here, IFNAR1 is linked to cancer.